News

Broncus Technologies (Broncus) has reported early results of a double-blinded, randomised, sham-controlled EASE (Exhale Airway Stents for Emphysema) trial, for patients with emphysema/COPD. Airway Bypass is a minimally-invasive

Sinovac Biotech (Sinovac) has received a revised production license from State Food and Drug Administration (SFDA) for Panflu.1, the company’s H1N1 vaccine. Reportedly, with the revised license, the

Galapagos has started a Phase II clinical study to evaluate Nanocort’s effectiveness in treating flares in multiple sclerosis (MS). Nanocort combines less frequent treatment with lower dosage and

Alkermes has initiated phase 2 clinical study of Alks 33, an investigational oral opioid modulator for the potential treatment of alcohol dependence and other central nervous system disorders.

Excluding the comparison of $57 million in fourth-quarter 2008 sales of oxycodone hydrochloride extended-release tablets (Oxy ER), fourth-quarter 2009 operational growth (net sales growth excluding the effect of

YM BioSciences has presented preclinical results for Cyt997 at the Aacr-Nci-Eortc meeting Molecular Targets and Cancer Therapeutics conference in Boston, Massachusetts. The presentation was made by Cytopia. Cyt997

Abbott and BG Medicine have entered into a development and commercialisation agreement for galectin-3, a novel biomarker that may play a role in detecting the development and progression

According to a warning letter dated August 12, 2009 and posted on November 17, 2009 on FDA’s Web site, FDA conducted an inspection at Abbott Molecular facility in

SIRO Clinpharm, a global contract research organization (CRO) has reported alliance with Mediscis, an early drug development company based in Poitiers and La Rochelle, France. Chetan Tamhankar, chief